Your session is about to expire
← Back to Search
Tranexamic Acid for Subdural Hematoma (TRACS Trial)
TRACS Trial Summary
This trial will investigate whether Tranexamic Acid (TXA) can help treat chronic subdural hematoma (CSDH), a common and debilitating condition for which there is no widely accepted medical treatment.
TRACS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2015 Phase 4 trial • 29 Patients • NCT02063035TRACS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a metal heart valve.I have a recent brain bleed without any old bleeding.I have a genetic condition that increases my risk of blood clots.You are currently being tested for cancer.I have visible blood in my urine.The doctor has any worries about your participation in the study.You have a long-lasting collection of blood outside the brain.I have atrial fibrillation but it's controlled with treatment.I have had a vascular stenting procedure in the past year.I have not had heart or blood vessel surgery in the last 6 months.I have an active cancer diagnosis.I am currently on hormone therapy for cancer.I am currently taking birth control pills.I am currently taking blood thinner medication.You are allergic to tranexamic acid or may have an allergy to it.I haven't had blood clots, stroke, or related issues in the past 6-12 months.I have had a blood clot in my veins or lungs without a known cause.
- Group 1: Tranexamic acid
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available openings for volunteers in this experiment?
"The research indicates that this clinical trial is actively recruiting patients. The original posting date was November 1st, 2015, with the most recent edit on November 8th, 2021."
To what end does Tranexamic Acid typically provide relief?
"Tranexamic Acid can be used to effectively manage hyperfibrinolysis, hemophilia, and bleeding."
Could you please share any other case studies that have used Tranexamic Acid?
"There are currently 69 clinical trials ongoing for Tranexamic Acid, with 29 of them in Phase 3. Out of the 305 total locations hosting trials for this medication, many of them are based in Kansas City, Kansas."
Share this study with friends
Copy Link
Messenger